Stay updated on Combination Nivolumab & PD-L1/IDO Vaccine in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Combination Nivolumab & PD-L1/IDO Vaccine in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Combination Nivolumab & PD-L1/IDO Vaccine in Melanoma Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    The page’s revision/version label was updated from v3.5.2 to v3.5.3, indicating a site release/build change without altering the study details shown.
    Difference
    0.1%
    Check dated 2026-04-24T05:58:05.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:29:35.000Z thumbnail image
  5. Check
    52 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0 and removed Revision: v3.4.3. This update seems to be a site versioning change rather than a modification to study content.
    Difference
    0.1%
    Check dated 2026-03-19T04:41:14.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T23:47:32.000Z thumbnail image
  7. Check
    88 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2; removed the government funding lapse operating-status notice and the previous Revision: v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-11T12:11:27.000Z thumbnail image
  8. Check
    95 days ago
    Change Detected
    Summary
    A site-wide notice about a lapse in government funding and operating status has been added, with guidance to opm.gov for updates. The page now shows a new revision tag (v3.4.1) replacing the previous (v3.4.0).
    Difference
    0.4%
    Check dated 2026-02-04T10:36:22.000Z thumbnail image

Stay in the know with updates to Combination Nivolumab & PD-L1/IDO Vaccine in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Combination Nivolumab & PD-L1/IDO Vaccine in Melanoma Clinical Trial page.